Table 1. Percentage of corneal edema scores of control, bevacizumab (2.5mg) and ranibizumab (1mg) groups.
Groups | Corneal edema score (%) |
||
Grade 1 | Grade 2 | Grade 3 | |
Saline | 0 | 20 | 80 |
Bevacizumab | 40 | 60 | 0 |
Ranibizumab | 60 | 40 | 0 |
Groups | Corneal edema score (%) |
||
Grade 1 | Grade 2 | Grade 3 | |
Saline | 0 | 20 | 80 |
Bevacizumab | 40 | 60 | 0 |
Ranibizumab | 60 | 40 | 0 |